title: Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
abstract: BACKGROUND
  The cardiovascular effects of transitions from exogenous subclinical hyperthyroidism to short-term overt hypothyroidism in patients treated for differentiated thyroid carcinoma remain unclear. The present study aims at evaluating the changes in multidirectional myocardial strain using two-dimensional (2D) speckle tracking during this controlled transition from exogenous subclinical hyperthyroidism to overt hypothyroidism.
  
  
  METHODS
  The study included 14 patients with differentiated thyroid carcinoma on thyrotropin suppressive thyroxine substitution who were subsequently withdrawn from thyroxine for 4 weeks. Cardiac function was assessed by 2D speckle tracking echocardiography before and 1 and 4 weeks after withdrawal and compared with values obtained in a control group of 24 individuals.
  
  
  RESULTS
  At baseline, the left ventricular dimensions were significantly higher in patients as compared with controls. Using 2D speckle tracking imaging, the patients had significantly impaired baseline myocardial systolic function in the circumferential (-16.0% ± 2.1% vs. -19.2% ± 3.0%, p = 0.001) and longitudinal (-17.1% ± 2.5% vs. -19.7% ± 3.0%, p = 0.001) directions as compared with controls. Withdrawal of thyroid hormone did not induce significant changes in left ventricular dimensions or systolic function. During the transition from exogenous subclinical hyperthyroidism to overt hypothyroidism, a significant improvement in circumferential and longitudinal systolic shortening was observed and returned to abnormal values when the patients were overt hypothyroid (circumferential strain: from -16.0% ± 2.1% to -18.6% ± 1.9% and -14.7% ± 2.8%, p < 0.005; longitudinal strain: from -17.1% ± 2.5% to -18.8% ± 1.4% and -16.3% ± 1.3%, p < 0.005).
  
  
  CONCLUSIONS
  A U-shaped relationship between a range of thyroid hormone levels (from hyper- to hypothyroid concentrations) and myocardial strains was observed. The clinical consequences of these findings remain to be determined but may point out an increased myocardial vulnerability even in states of moderate subclinical hyperthyroidism and short-term hypothyroidism.
authors.affiliation: Department of Endocrinology and Metabolism, The Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Randa M
authors.initials: RM
authors.lastname: Abdulrahman
authors.forename: Victoria
authors.initials: V
authors.lastname: Delgado
authors.forename: Hendrieke C
authors.initials: HC
authors.lastname: Hoftijzer
authors.forename: Arnold C T
authors.initials: AC
authors.lastname: Ng
authors.forename: See Hooi
authors.initials: SH
authors.lastname: Ewe
authors.forename: Nina Ajmone
authors.initials: NA
authors.lastname: Marsan
authors.forename: Eduard R
authors.initials: ER
authors.lastname: Holman
authors.forename: Guido C
authors.initials: GC
authors.lastname: Hovens
authors.forename: Eleonora P
authors.initials: EP
authors.lastname: Corssmit
authors.forename: Johannes A
authors.initials: JA
authors.lastname: Romijn
authors.forename: Jeroen J
authors.initials: JJ
authors.lastname: Bax
authors.forename: Johannes W A
authors.initials: JW
authors.lastname: Smit
mesh_terms: D000328:Adult; D000368:Aged; D004452:Echocardiography / Q000379:methods; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000503:physiopathology*; D007037:Hypothyroidism / Q000150:complications / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009206:Myocardium / Q000378:metabolism*; D013963:Thyroid Hormones / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D013972:Thyrotropin / Q000378:metabolism; D013974:Thyroxine / Q000378:metabolism
chemical_list: D013963:Thyroid Hormones; D013972:Thyrotropin; D013974:Thyroxine